It was William Shakespeare who wrote in his Sonnet 18 “summer’s lease hath all too short a date.” If you’re looking to make ...

Lilly’s previous investment announcements for the site were an initial $2.1 billion in May 2022, an additional $1.6 billion in April 2023, and an additional $5.3 billion in May 2024.

LEBANON, Ind. — Eli Lilly and Company announced it has more than doubled its investment in its Lebanon manufacturing site. The new $5.3 billion commitment increases the company's total ...

Lilly said the extra investment at the nearly 600-acre site in Lebanon will enhance its capacity to manufacture tirzepatide, the active ingredient in both Mounjaro and Zepbound.

At the company’s Lebanon groundbreaking in April 2023, Lilly announced an additional $1.6 billion investment and 200 new jobs at the site.

Eli Lilly and Company kicked off the second day of the Indiana Global Economic Summit by announcing a $5.3 billion investment slated for a major tech park.

LEBANON, Ind. — Indianapolis-based pharmaceutical giant Lilly on Wednesday announced another billion-dollar project coming to Boone County. The project will be in the LEAP Research and Innovation ...

The new facility builds on Lilly's ongoing expansion in Lebanon. In May 2022, Lilly announced a $2.1bn investment in two new sites for active ingredients and modalities.

LEBANON, Ind. – Eli Lilly and Company will invest an additional $4.5 billion in Boone County to create a new center for advanced manufacturing and drug development. The Lilly Medicine Foundry ...

In May 2022, Lilly announced plans to invest $2.1 billion in two new manufacturing sites in Lebanon to expand its network for active ingredients and new modalities, such as genetic medicines.